Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

NITROGLYCERIN vs NIVOLUMAB\RELATLIMAB-RMBW: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

NITROGLYCERIN vs NIVOLUMAB\RELATLIMAB-RMBW: Safety Overview

Metric NITROGLYCERIN NIVOLUMAB\RELATLIMAB-RMBW
Total FAERS Reports 7,431 500
Deaths Reported 962 120
Death Rate 12.9% 24.0%
Hospitalizations 3,185 147
Average Patient Age 69.7 yrs 64.8 yrs
% Female Patients 63.8% 33.2%
FDA Approval Date Approved Prior to Jan 1, 1982 N/A
Manufacturer Boiron N/A
Route ORAL N/A
Marketing Status Discontinued N/A